AppSec Consulting Announces Launch of its Managed Data Protection Officer (DPO) Service

AppSec Consulting Announces Launch of its Managed Data Protection Officer (DPO) Service Allowing Organizations to Comply with (GDPR)

An expanding number of organizations are getting in front of these new requirements as a good business practice, and they are partnering with AppSec Consulting to serve as their DPO.”

— Ryan Hogan, Director of Strategic Advisory Services

SAN JOSE, CALIFORNIA, UNITED STATES, May 10, 2018 /EINPresswire.com/ — AppSec Consulting, a leader in providing Cybersecurity, IT Risk Management and Data Privacy solutions, announced today the launch of its Managed Data Protection Officer (MDPO) Service to assist organizations (controllers and/or processors) who are in need of a properly qualified Data Protection Officer. Per Section 4 and Article 39 of the GDPR, “the data protection officer shall be designated on the basis of professional qualities and, in particular, expert knowledge of data protection law and practices and the ability to fulfil the tasks…” This service allows global organizations who are required to comply with the EU’s General Data Protection Regulation (GDPR) to appropriately satisfy this requirement.

Later this month, GDPR becomes effective and organizations that are subject to the regulation may be required to have a properly qualified Data Protection Officer (DPO). The DPO is responsible for informing the controller or processor and employees about their obligations pursuant to the regulation’s data protection provisions; to monitor compliance with the regulation regarding the protection of personal information, including assignment of roles and responsibilities, staff awareness training and operational audits; and to provide advice where requested as it relates to data protection impact assessment and to monitor the performance of the organization’s privacy program.

To comply with GDPR, AppSec Consulting recommends organizations immediately assess their privacy programs and level of overall readiness. This includes performing a data privacy impact assessment, mapping in-scope data assets and having a well-defined data subject access request process in place.

Ryan Hogan, Director of Strategic Advisory Services for AppSec Consulting, and a well-known cybersecurity and data privacy expert said, “Many organizations are just now waking up to the impact GDPR will have on their businesses. Our consulting team has been busy advising clients on how to best meet or exceed GDPR’s new requirements and build a sustainable and appropriate privacy program. An expanding number of organizations are getting in front of these new requirements as a good business practice, and they are partnering with AppSec Consulting to serve as their DPO. Our team of expert consultants has helped prepare a number of leading organizations who are seeing a quick return on their investment. ”

AppSec Consulting has also announced their online U.S Privacy Shield and GDPR training program, designed to help employees of impacted organizations understand and meet the new requirements.

Visit AppSec Consulting’s Data Privacy page for more information about the regulations and how to get started.

Klaudia Nord
AppSec Consulting
4082241110
email us here


Source: EIN Presswire

HumanaCare Acquires Virtual Health Platform TranQool

HumanaCare expands access with cutting-edge virtual platform

TORONTO, ONTARIO, CANADA, May 10, 2018 /EINPresswire.com/ — HumanaCare, a leading provider of employee and member health services is pleased to announce the acquisition of TranQool, a virtual health platform.

"Combining HumanaCare and TranQool drives innovation and employee engagement in our health and wellness solutions. TranQool gives us the opportunity to deliver care virtually, while providing a robust platform to expand access to our existing Employee Assistance Programs, Medical Second Opinion, Disability Support, Caregiving/Healthcare Navigation and Chronic Disease Management Services" said Jamie Marcellus, President of HumanaCare. " TranQool deepens our capabilities in a number of key areas as well as provides an exceptional direct to consumer market entry-point. We look forward to working with the dedicated team of professionals at TranQool."

"We are excited about joining the HumanaCare team. The TranQool platform will provide HumanaCare members with chat and video access to counsellors and health care professionals. The growing need for online access to health services is a shift that is happening and you're seeing HumanaCare and TranQool leading the way to providing solutions designed specifically for health care applications in the employee benefit arena" said Saeed Zeinali, Co-Founder of TranQool. "HumanaCare's current and future clients will benefit greatly from the choice and convenience of online access."

The transaction closed on May 8th, 2018.

About HumanaCare:

HumanaCare has more than 35 years of Canadian healthcare experience delivering improved outcomes through our Employee Assistance Programs, Disability Support Services, Medical Second Opinion Services and Health Services (such as healthcare navigation, Chronic Disease support and specialized case management services, for more details, please visit http://www.humanacare.com

About TranQool:

TranQool is a virtual health platform that provides access to mental health services to people across Canada. Mental health is as important as physical health and TranQool's mission is to increase access to resources in the mental health industry. For more details, please visit http://www.tranqool.com

Jamie Marcellus
HumanaCare
1-800-661-8193 ext 264
email us here


Source: EIN Presswire

2nd Annual: Highly Potent Active Pharmaceutical Ingredients Conference – Under 2 Weeks Left!

LONDON, UNITED KINGDOM, May 10, 2018 /EINPresswire.com/ — SMi's 2nd annual conference and workshops on Highly Potent Active Pharmaceutical Ingredients will be taking place in London UK, between the 21st – 23rd May 2018. There is still time to register online, with special rates available.

Hear from the speakers themselves, who will be presenting key topics and issues within highly potent apis, especially discussing the future of cross contamination issues.

"Look at ADCs, highly potent APIs that previously were too toxic (including too narrow a therapeutic window) have been reborn when used in a much lower but highly targeted manner." – [CHAIR] – HPAPI Project Services

"I believe that continuous manufacturing and robotic systems will be a real game changer for the HPAPI industry. The industry is just in the early stages of this rapidly developing technology." – Affygility Solutions

"The growing demand for drugs containing HPAPIs and the increased need for targeted therapeutics strengthen the importance of biotechnology, due to the high selectivity of biological drugs in connection with their very specific mechanism of action." – Gedeon Richter

NETWORK WITH:

Dep. Head of Drug Substance Development Division | Developing chemical engineer | Development Scientist | Director of Containment & Micronisation | Director of Operations | EHS Director | EHS Manager | Executive | Head of EHS | Head of Manufacturing | Health, Safety Environment | Managing Director | Occupational Hygiene Manager | Principle Scientist | Principal Occupational Hygienist | Principal Scientist Drug Substance Development | Production Manager | Sales Manager | Scale Up Chemist | Senior Lab Techniciton | Senior Research Technician +more!

For the full attendee list and speaker interviews, visit the download centre online at: www.highlypotentapi.com/ein

SMi presents the 2nd Annual:

Highly Potent Active Pharmaceutical Ingredients (HPAPI)
Date: 21st – 22nd May 2018
Workshops: 23rd May 2018
Location: Holiday Inn Kensington Forum, London UK
Website: http://www.highlypotentapi.com/ein

—end—

Contact Information:

For all media inquiries contact Pav Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
SMi Group
2078276048
email us here


Source: EIN Presswire

Explore Future Methods of the Optimisation of Freeze Drying Cycles, this June

Reduction of drying time – while it can be argued that continuous processing is not necessary for many freeze-dried products, there is still a need to reduce the drying time…”

— [Chariman] – Janssen

LONDON, UNITED KINGDOM, May 10, 2018 /EINPresswire.com/ — The updated agenda for SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology is available online. See which big pharma companies are attending and can hear from and who will be exploring what the future of pharma freeze drying holds.

This Week's Spotlight: Sanofi + Exclusive Panel Discussion

– Optimising Freeze Drying Cycles –

Freeze-drying involves three basic steps—freezing (solidification), primary drying (ice sublimation), and secondary drying (moisture desorption) – which can take several days to complete. A fundamental goal of freeze-drying is to produce a well-dried product with elegant cake appearance, short reconstitution time, long shelf life, and complete recovery of activity on rehydration, among other requirements. Two major considerations for optimisation of a freeze-drying process are the stability of the drug product, during the process itself and during the storage period after the cycle is terminated. *Source: PharmTech

Mostafa Nakach, Head of Pharmaceutical Engineering, Sanofi will be presenting a Keynote Presentation on: 'Optimisation of Industrial Freeze Drying Cycle.' – Day 1 | 11:00

Mostafa will look into the two "old" products of the 60’s (called 'A and B') performed with historical cycles which exhibit aspects issues. The manufacturing of both products was intended to be carried out using a new and state of the art freeze dryer. Due to the age of the products, very few process, or physical chemistry data was available. Therefore, the manufacturing process was developed and optimized based on product knowledge, new freeze dryer knowledge, simulation and process modelling.

The objective of the presentation is to share how the methodology was applied and to outline the concrete benefit for both products.

– Future Directions of the Field –

Although an old process, pharmaceutical freeze drying is ever evolving with new trends and approaches being used for pharmaceutical formulation.

Hear from an exclusive panel of Big Pharma companies as they explore 'The Future of Novel Technology for Predicting Cycles Within the Lyophilisation Field.' – Day 2 | 15:20

Below is a summary of the panel discussion:

– The current novel technologies which have been recently introduced into the market
– The benefits of these technologies over existing technologies
– Barriers to entry into implementation e.g. regulations, pricing etc
– How can technologies be further developed?

Panelists:
– Paul Matejtschuk, Principal Scientist, NIBSC
– Sune Klint Andersen, Principal Scientist Spray Drying, Janssen
– Kevin Ward, Director of R&D, BioPharma Process Systems Ltd
– Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D

Download your copy of the brochure

Take a look at last year's attendee list to see who you could meet this June!

Further information and the complete brochure is available at: www.pharmafreezedrying.com/ein

SMi presents the 6th annual conference:
Pharmaceutical Freeze Drying Technology
Date: 13th – 14th June 2018
Workshops: 12th June 2018
Location: Holiday Inn Kensington Forum, London UK
Website: www.pharmafreezedrying.com/ein

—end—

Contact Information:

For all media inquiries contact Pav Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
SMi Group
2078276048
email us here


Source: EIN Presswire

India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics

In-Vitro Diagnostics Market Growth Rates %s

LONDON, GREATER LONDON, UK, May 10, 2018 /EINPresswire.com/ — The Indian market for equipment used for laboratory tests to detect disease is growing at a remarkable 8.6% year on year, a report from The Business Research Company shows, just ahead of China where the market’s annual increase is 8.5%. The USA and Australia are the only two developed countries where growth even approaches these figures – the USA’s is 5.3% and Australia’s 4.4%. No Western European country is seeing growth above 3%.
The four leading markets for growth, India, China, the USA and Japan have all seen it decrease from the rate they were achieving to 2017. The markets in the UK and Australia, however, are seeing increased growth – the UK’s by 0.6 percentage points a year and Australia’s by an impressive 3.7 percentage points.

India’s market for in-vitro diagnostics was worth $2.1 billion in 2017. It is the world’s fifth largest, but will soon overtake Japan’s and be in fourth place. The USA, with 21% of the total, and China, with 16% are the world’s two largest. Germany is in third place, with 4.3% of the global total. Boosted by India, and especially China, Asia Pacific is both the largest and the fastest-growing region for this market.
In-vitro diagnostics is the largest segment of the global medical equipment market, accounting for 15.1% of the total, closely followed by cardiovascular devices at 15% and by other diagnostic devices, some way behind at 11.4%. The fastest-growing segment of the global medical treatment equipment market is for devices that treat neurological diseases such as Parkinson’s Disease. That segment is growing at 7.8% year on year. Second fastest is anaesthesia and respiratory disease devices, growing at 5.9% annually and third is surgical equipment, which is achieving 5.5% a year. The fastest-growing segment of the whole market, however, is not directly treatment-related: it is hospital supplies equipment, rising at at 11.8%a year. Patient monitoring devices is another fast riser at 7.1% a year. The global medical devices market was worth $380 billion in 2016 and is predicted to grow by over $100 billion by 2020 at a CAGR of 6.7%.

Point-of-care diagnostics are the largest segment of the global in-vitro diagnostic equipment market, accounting for 34% of the total in 2017. Demand for these devices is buoyant as they provide rapid results, are cost effective and have advanced diagnosis features for patients. The number of patients seeking treatments at local physician offices, retail clinics and in patient homes are increasing, thus boosting the demand for point-of-care testing devices. Companies in this market are focusing on developing more user friendly, reliable and efficient point of care devices. For instance, in July 2016, Spartan Bioscience introduced Spartan Cube, the world's smallest DNA-testing system that enables anybody to quickly perform DNA testing. Philips also launched a new handheld blood test, Handheld Minicare I-20 system used for diagnosing heart attacks in emergency departments which provide results within 10 minutes.
The in-vitro diagnostic equipment market is highly concentrated: the top five competitors made up over 80% of the total market in 2017. Despite this, further consolidation is under way. Merger and acquisition activity in the in-vitro diagnostic market in the last 3 years has been at a high level. Roche, Thermo Fisher Scientific, Grifols, Carlyle and Beckman Coulter are among companies in the industry that have completed deals in the last three years.

Where To Learn More
Read the In-Vitro Diagnostics Global Market Report 2018 from The Business Research Company for information on the following:
Markets Covered: Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Haemostasis; Haematology; Immunohematology
Companies Covered: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.),Abbott Laboratories Inc., Thermo Fisher Scientific Inc.
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data Segmentations: Global in-vitro diagnostics market historic and forecast size and growth rates for the world, 7 regions and 12 countries, Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Haemostasis; Haematology; Immunohematology segments historic and forecast size and growth rates for the world, 7 regions and 12 countries, Haemostasis; Haematology; for 12 countries, Immunohematology segments size 2017 for 12 countries, global competitor sales and market shares.
Healthcare market historic and forecast size and growth rates for the world, 7 regions and 12 countries, healthcare market size, percentage of gdp, global, healthcare per capita expenditure, by country, healthcare services market historic and forecast size and growth rates, and split by segments 2017, global.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Interested to know more? Here is a list of reports similar to “In-Vitro Diagnostics Global Market Report 2018”:
In-Vitro Diagnostics Global Market Report 2018
Medical Equipment Global Market Report 2018
Healthcare Services Global Market Report 2018

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire

The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead

Cadiovascular Devices Market Company Share %s 2017

Cadiovascular Devices Market Company Share %s 2017

LONDON, GREATER LONDON, UK, May 10, 2018 /EINPresswire.com/ — Medtronic, Inc is the company with the largest share of the global market for devices to treat diseases related to the heart, at 19%, a report from The Business Research Company shows. The company is continuously investing in R&D, in order to retain or increase its share and maintain sales in a global market in where growth is slower than that of gdp. In 2014, for instance Medtronic launched a new external heart monitor device, its SEEQ Wearable Cardiac Monitoring System, which is a wire-free and adhesive patch that can be worn on skin for up to 30 days and that helps diagnose the cause of abnormal heart beats in patients experiencing vertigo, syncope, palpitations or shortness of breath. The player with the second largest share at 14%, Abbott Laboratories, also innovates to stay ahead: in July 2016, it obtained approval from the US Federal Drugs Administration for the market’s first fully absorbable stent, Absorb GT1 BVS. The cardiovascular devices market is relatively, with five global players accounting for 54.1% of the total in 2017. Further consolidation is under way; merger and acquisition activity in the last four years has been high. Abbott, Beckton Dickinson, Cardinal Health, Philips, Medtronic, St Jude and Boston Specific were among companies that completed takeovers or mergers.

Products in the market include arrhythmia detectors, non-invasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs and defibrillators. The main segments are cardiovascular surgery devices, worth 37% of the total, cardiac rhythm management devices, accounting for 23% and interventional cardiology devices, at 17%.
Growth in the biggest markets for cardiovascular devices, China and the USA, has dropped recently, though remaining strongly positive, but global market growth, however, has fallen from 5.1% to only 2.4%, below the growth rate for global gdp. In Japan, the third largest, however, growth has picked up, from 4.7% to 5% year on year.
The cardiovascular devices market is relatively fragmented, with few global players. The top five competitors in the market made up 54.1% of the total market share in 2017.
Merger and acquisition activity in the cardiovascular devices market in the last four years has been high. Leading deals are done by Abbott, Beckton Dickinson, Cardinal Health, Philips, Medtronic, St Jude and Boston Specific.

Where To Learn More
Read the Cardiovascular Devices Global Market Report 2018 from The Business Research Company for information on the following:
Markets Covered: Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM) Devices; Interventional Cardiology Devices; Defibrillator Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device; Electrophysiology Devices; Cardiac Assist Devices
Companies Covered: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc, Edwards Lifesciences
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data Segmentations: Global cardiovascular devices market historic and forecast size and growth rates for the world, 7 regions and 12 countries, Cardiovascular Surgery Devices ; Cardiac Rhythm Management (CRM) Devices ; Interventional Cardiology Devices ; Defibrillator Devices ; Peripheral Vascular Devices Prosthetic Heart Valve Device ; Electrophysiology Devices ; Cardiac Assist Devices segments historic and forecast size and growth rates for the world, 7 regions and 12 countries, Pancreatic Cancer; Skin Cancer; Ovarian Cancer; Bladder Cancer, for 12 countries, Thyroid Cancer segments size 2017 for 12 countries, global competitor sales and market shares.
Healthcare market historic and forecast size and growth rates for the world, 7 regions and 12 countries, healthcare market size, percentage of gdp, global, healthcare per capita expenditure, by country, healthcare services market historic and forecast size and growth rates, and split by segments 2017, global.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Interested to know more? Here is a list of reports similar to “Cardiovascular Devices Global Market Report 2018”:
Cardiovascular Devices Global Market Report 2018
Medical Equipment Global Market Report 2018
Healthcare Services Global Market Report 2018

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire

Ethylene Acrylic Acid Copolymer Market 2018-2021: World Consumption and Sales Analysis Market Report

PUNE, INDIA, May 10, 2018 /EINPresswire.com/ — Global Ethylene Acrylic Acid Copolymer Market

WiseGuyRerports.com Presents “Global Ethylene Acrylic Acid Copolymer Market 2018-2022” New Document to its Studies Database. The Report Contain 108 Pages With Detailed Analysis.

Description

EAA copolymer comprises ethylene and acrylic acid and exhibits properties of both the compounds. The compound is dispersible in aqueous alkali and amines.

The analysts forecast the global ethylene acrylic acid copolymer market to grow at a CAGR of 8.63% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global ethylene acrylic acid copolymer market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/3156035-global-ethylene-acrylic-acid-copolymer-market-2018-2022

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The Global Ethylene Acrylic Acid Copolymer Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Arkema Group
• DowDuPont
• Exxon Mobil
• Honeywell International
• LyondellBasell Industries Holdings

Market driver
• Increasing demand in the food packaging industry
• For a full, detailed list, view our report

Market challenge
• Fluctuations in raw-material prices
• For a full, detailed list, view our report

Market trend
• Rise in demand for bio-based acrylic acid
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3156035-global-ethylene-acrylic-acid-copolymer-market-2018-2022

Table of Contents -Major Key Points

PART 01: EXECUTIVE SUMMARY 

PART 02: SCOPE OF THE REPORT 

PART 03: RESEARCH METHODOLOGY 

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Adhesives – Market size and forecast 2017-2022
• Barrier coating – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE 

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• APAC – Market size and forecast 2017-2022
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK 

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Rise in demand for bio-based acrylic acid
• Increasing M&A activities
• Increasing demand for flexible liquid packaging pouches

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
• Key market vendors

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Arkema Group
• DowDuPont
• Exxon Mobil
• Honeywell International
• LyondellBasell Industries Holdings

……..CONTINUED

 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Smoking Cessation and Nicotine De-Addiction Products Market Major Manufacturers, Trends, Demand, Share Analysis to 2025

Smoking Cessation and Nicotine De-Addiction Products Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, INDIA, May 10, 2018 /EINPresswire.com/ — Smoking Cessation and Nicotine De-Addiction Products Market 2018

Wiseguyreports.Com adds “Smoking Cessation and Nicotine De-Addiction Products Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Smoking Cessation and Nicotine De-Addiction Products Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Smoking Cessation and Nicotine De-Addiction Products Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Smoking Cessation and Nicotine De-Addiction Products market status and forecast, categorizes the global Smoking Cessation and Nicotine De-Addiction Products market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The major manufacturers covered in this report 
NJOY 
Johnson & Johnson 
GSK 
Pfizer 
VMR Products 
Nicotek 
Lorillard 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3142308-global-smoking-cessation-and-nicotine-de-addiction-products

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
Asia-Pacific 
South America 
Middle East & Africa

The regional scope of the study is as follows: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
by Nicotine Replacement Therapy Products 
Nicotine Gums 
Nicotine Transdermal Patches 
Nicotine Lozenges 
Nicotine Sprays 
Nicotine Inhalers 
Nicotine Sublingual Tablets 
by Drug Therapy 
Zyban (bupropion) 
Chantix/Champix (varenicline)) 
E-cigarettes 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Retail 
Online Sale

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3142308-global-smoking-cessation-and-nicotine-de-addiction-products

Major Key Points in Table of Content:

Global Smoking Cessation and Nicotine De-Addiction Products Market Research Report 2018 
1 Smoking Cessation and Nicotine De-Addiction Products Market Overview 
1.1 Product Overview and Scope of Smoking Cessation and Nicotine De-Addiction Products 
1.2 Smoking Cessation and Nicotine De-Addiction Products Segment by Nicotine Replacement Therapy Products 
1.2.1 Global Smoking Cessation and Nicotine De-Addiction Products Production and CAGR (%) Comparison by Nicotine Replacement Therapy Products (Product Category)(2013-2025) 
1.2.2 Global Smoking Cessation and Nicotine De-Addiction Products Production Market Share by Nicotine Replacement Therapy Products (Product Category) in 2017 
1.2.3 Nicotine Gums 
1.2.4 Nicotine Transdermal Patches 
1.2.5 Nicotine Lozenges 
1.2.6 Nicotine Sprays 
1.2.7 Nicotine Inhalers 
1.2.8 Nicotine Sublingual Tablets 
1.3 Smoking Cessation and Nicotine De-Addiction Products Segment by Drug Therapy 
1.3.1 Zyban (bupropion) 
1.3.2 Chantix/Champix (varenicline)) 
1.3.3 E-cigarettes 
1.4 Global Smoking Cessation and Nicotine De-Addiction Products Segment by Application 
1.4.1 Smoking Cessation and Nicotine De-Addiction Products Consumption (Sales) Comparison by Application (2013-2025) 
1.4.2 Retail 
1.4.3 Online Sale 
1.5 Global Smoking Cessation and Nicotine De-Addiction Products Market by Region (2013-2025) 
1.5.1 Global Smoking Cessation and Nicotine De-Addiction Products Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.5.2 North America Status and Prospect (2013-2025) 
1.5.3 Europe Status and Prospect (2013-2025) 
1.5.4 Asia-Pacific Status and Prospect (2013-2025) 
1.5.5 South America Status and Prospect (2013-2025) 
1.5.6 Middle East & Africa Status and Prospect (2013-2025) 
1.6 Global Market Size (Value) of Smoking Cessation and Nicotine De-Addiction Products (2013-2025) 
1.6.1 Global Smoking Cessation and Nicotine De-Addiction Products Revenue Status and Outlook (2013-2025) 
1.6.2 Global Smoking Cessation and Nicotine De-Addiction Products Capacity, Production Status and Outlook (2013-2025)

…..

7 Global Smoking Cessation and Nicotine De-Addiction Products Manufacturers Profiles/Analysis 
7.1 NJOY 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Smoking Cessation and Nicotine De-Addiction Products Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 NJOY Smoking Cessation and Nicotine De-Addiction Products Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Johnson & Johnson 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Smoking Cessation and Nicotine De-Addiction Products Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Johnson & Johnson Smoking Cessation and Nicotine De-Addiction Products Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 GSK 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Smoking Cessation and Nicotine De-Addiction Products Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 GSK Smoking Cessation and Nicotine De-Addiction Products Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Pfizer 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Smoking Cessation and Nicotine De-Addiction Products Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Pfizer Smoking Cessation and Nicotine De-Addiction Products Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 VMR Products 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Smoking Cessation and Nicotine De-Addiction Products Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 VMR Products Smoking Cessation and Nicotine De-Addiction Products Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.5.4 Main Business/Business Overview 
7.6 Nicotek 
7.7 Lorillard 

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Hospital Information Systems (HIS) Market Major Manufacturers, Trends, Demand, Share Analysis to 2025

Hospital Information Systems (HIS) Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, INDIA, May 10, 2018 /EINPresswire.com/ — Hospital Information Systems (HIS) Market 2018

Wiseguyreports.Com adds “Hospital Information Systems (HIS) Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Hospital Information Systems (HIS) Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Hospital Information Systems (HIS) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Hospital Information Systems (HIS) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hospital Information Systems (HIS) market by companies, region, type and end-use industry.

This report focuses on the global top players, covered 
Cerner Corp. 
Epic Systems Corp. 
McKesson Corp. 
Siemens Healthcare Ltd 
Agfa Healthcare Corp. 
Allscripts 
Healthcare Solutions Inc. 
Computer Program and Systems Inc. 
CompuGroup Medical AG 
GE Healthcare 
Keane Care Inc 
Medical Information Technology Inc

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3133245-global-hospital-information-systems-his-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India

Market segment by Type, the product can be split into 
HMIS 
HCIS 
GMIS

Market segment by Application, Hospital Information Systems (HIS) can be split into 
Information Service 
Payment 
Others

Key Stakeholders 
Hospital Information Systems (HIS) Manufacturers 
Hospital Information Systems (HIS) Distributors/Traders/Wholesalers 
Hospital Information Systems (HIS) Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3133245-global-hospital-information-systems-his-market-size-status-and-forecast-2025

Major Key Points in Table of Content:

Global Hospital Information Systems (HIS) Market Size, Status and Forecast 2025 
1 Industry Overview of Hospital Information Systems (HIS) 
1.1 Hospital Information Systems (HIS) Market Overview 
1.1.1 Hospital Information Systems (HIS) Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Hospital Information Systems (HIS) Market Size and Analysis by Regions (2013-2018) 
1.2.1 United States 
1.2.2 Europe 
1.2.3 China 
1.2.4 Japan 
1.2.5 Southeast Asia 
1.2.6 India 
1.3 Hospital Information Systems (HIS) Market by Type 
1.3.1 HMIS 
1.3.2 HCIS 
1.3.3 GMIS 
1.4 Hospital Information Systems (HIS) Market by End Users/Application 
1.4.1 Information Service 
1.4.2 Payment 
1.4.3 Others

2 Global Hospital Information Systems (HIS) Competition Analysis by Players 
2.1 Hospital Information Systems (HIS) Market Size (Value) by Players (2013-2018) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Cerner Corp. 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.2 Epic Systems Corp. 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.3 McKesson Corp. 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.4 Siemens Healthcare Ltd 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.5 Agfa Healthcare Corp. 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.6 Allscripts 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.7 Healthcare Solutions Inc. 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.8 Computer Program and Systems Inc. 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.9 CompuGroup Medical AG 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 
3.10 GE Healthcare 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Hospital Information Systems (HIS) Revenue (Million USD) (2013-2018) 

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Organic Coconut Oil Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

Organic Coconut Oil Market 2018 Global and China Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, May 10, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Organic Coconut Oil Market 2018 Global and China Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Organic Coconut Oil Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Organic Coconut Oil Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Global Organic Coconut Oil market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Tantuco Enterprises
Greenville Agro Corporation
Samar Coco Products
CIIF OMG
Primex Group
SC Global
Phidco
PT.Indo Vegetable Oil
P.T. Harvard Cocopro
Naturoca
PT SIMP
Sumatera Baru
KPK Oils & Proteins
Karshakabandhu Agritech
Kalpatharu Coconut
Prima Industries Limited
Kerafed

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Organic Coconut Oil in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Virgin Organic Coconut Oil
Refined Organic Coconut Oil

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Food Industry
Chemical Industry
Beauty and Cosmetics Industry
Medical Industry
Other

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2980228-global-organic-coconut-oil-market-research-report-2018

Table of Contents

Global Organic Coconut Oil Market Research Report 2018
1 Organic Coconut Oil Market Overview
1.1 Product Overview and Scope of Organic Coconut Oil
1.2 Organic Coconut Oil Segment by Type (Product Category)
1.2.1 Global Organic Coconut Oil Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Organic Coconut Oil Production Market Share by Type (Product Category) in 2017
1.2.3 Virgin Organic Coconut Oil
1.2.4 Refined Organic Coconut Oil
1.3 Global Organic Coconut Oil Segment by Application
1.3.1 Organic Coconut Oil Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Food Industry
1.3.3 Chemical Industry
1.3.4 Beauty and Cosmetics Industry
1.3.5 Medical Industry
1.3.6 Other
1.4 Global Organic Coconut Oil Market by Region (2013-2025)
1.4.1 Global Organic Coconut Oil Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Organic Coconut Oil (2013-2025)
1.5.1 Global Organic Coconut Oil Revenue Status and Outlook (2013-2025)
1.5.2 Global Organic Coconut Oil Capacity, Production Status and Outlook (2013-2025)

…..

7 Global Organic Coconut Oil Manufacturers Profiles/Analysis
7.1 Tantuco Enterprises
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Organic Coconut Oil Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Tantuco Enterprises Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Greenville Agro Corporation
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Organic Coconut Oil Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Greenville Agro Corporation Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Samar Coco Products
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Organic Coconut Oil Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Samar Coco Products Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 CIIF OMG
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Organic Coconut Oil Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 CIIF OMG Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Primex Group
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Organic Coconut Oil Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Primex Group Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 SC Global
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Organic Coconut Oil Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 SC Global Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Phidco
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Organic Coconut Oil Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Phidco Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 PT.Indo Vegetable Oil
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Organic Coconut Oil Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 PT.Indo Vegetable Oil Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 P.T. Harvard Cocopro
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Organic Coconut Oil Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 P.T. Harvard Cocopro Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Naturoca
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Organic Coconut Oil Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Naturoca Organic Coconut Oil Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 PT SIMP
7.12 Sumatera Baru
7.13 KPK Oils & Proteins
7.14 Karshakabandhu Agritech
7.15 Kalpatharu Coconut
7.16 Prima Industries Limited
7.17 Kerafed

At any Query @ https://www.wiseguyreports.com/enquiry/2980228-global-organic-coconut-oil-market-research-report-2018

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire